Development of gene-specific double-stranded RNA drugs

References

• Lavorgna G, Dahary D, Lehner B, Sorek R, Sanderson CM, Casari G. In search of antisense. Trends Biochem Sci 2004; 29:88–94.
   PubMed Web of Science ®Google Scholar
• Denli AM, Hannon GJ. RNAi: an ever-growing puzzle. Trends Biochem Sci 2003;28:196–201.
   PubMed Web of Science ®Google Scholar
• Kim VN. RNA interference in functional genomics and medicine. J Korean Med Sci 2003;18:309–18.
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411: 494–8.
   PubMed Web of Science ®Google Scholar
• Schwarz DS, Hutvagner G, Haley B, Zamore PD. Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol Cell 2002;10: 537–48.
   PubMed Web of Science ®Google Scholar
• Nykanen A, Haley B, Zamore PD. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 2001;107:309–21.
   Google Scholar
• Chiu YL, Rana TM. RNAi in human cells: basic structural and functional features of small interfering RNA. Mol Cell 2002;10:549–61.
   PubMed Web of Science ®Google Scholar
• Aza-Blanc P, Cooper CL, Wagner K, Batalov S, Deveraux QL, Cooke MP. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol Cell 2003;12:627–37.
   Google Scholar
• Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003;115:199–208.
   PubMed Web of Science ®Google Scholar
• Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003; 115: 209–16. Erratum in:. Cell 2003;115:505.
   Google Scholar
• Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 2001;106:23–34.
   Web of Science ®Google Scholar
• Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001;293:834–8.
   PubMed Web of Science ®Google Scholar
• Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev 2001;15:2654–9.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281–97.
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T. New microRNAs from mouse and human. RNA 2003;9:175–9.
   Google Scholar
• Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425:415–9.
   PubMed Web of Science ®Google Scholar
• Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004;303: 95–8.
   Google Scholar
• Moss EG, Taylor JM. Small-interfering RNAs in the radar of the interferon system. Nat Cell Biol 2003;5:771–2.
   PubMed Web of Science ®Google Scholar
• Sen GC. Viruses and interferons. Annu Rev Microbiol 2001; 55:255–81.
   PubMed Web of Science ®Google Scholar
• Bitko V, Batik S. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol 2001;1:34.
   PubMedGoogle Scholar
• Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003;5:834–9.
   Google Scholar
• Persengiev SP, Zhu X, Green MR. Nonspecific, concentra-tion-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 2004;10:12–8.
   Google Scholar
• Bridge A J, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003;34:263–4.
   Google Scholar
• Kim DH, Longo M, Han Y, Lundberg P, Cantin E, Rossi JJ. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 2004;22:321–5.
   PubMed Web of Science ®Google Scholar
• Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett 2003; 543:51–4.
   PubMed Web of Science ®Google Scholar
• Konishi M, Wu CH, Wu GY. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology 2003;38:842–50.
   Google Scholar
• McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003;21:639–44.
   PubMed Web of Science ®Google Scholar
• Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 2003;37: 764–70.
   PubMed Web of Science ®Google Scholar
• Ying C, De Clercq E, Neyts J. Selective inhibition of hepatitis B virus replication by RNA interference. Biochem Biophys Res Commun 2003;309:482–4.
   PubMed Web of Science ®Google Scholar
• Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum 0, Galun E. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 2003;8:769–76.
   Google Scholar
• Jia Q, Sun R. Inhibition of ganunaherpesvirus replication by RNA interference. J Virol 2003;77:3301–6.
   PubMed Web of Science ®Google Scholar
• Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 2002;21: 6041–8.
   PubMed Web of Science ®Google Scholar
• Capodici J, Kariko K, Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA inter-ference. J Immunol 2002;169: 5196–201.
   Google Scholar
• Hu WY, Myers CP, Kilzer JM, Pfaff SL, Bushman FD. Inhibition of retroviral pathogenesis by RNA interference. Curr Biol 2002;12:1301–11.
   Google Scholar
• Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, et al. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002;8:681–6.
   PubMed Web of Science ®Google Scholar
• Coburn GA, Cullen BR. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 2002;76:9225–31.
   PubMed Web of Science ®Google Scholar
• Surabhi RM, Gaynor RB. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J Virol 2002;76:12963–73.
   PubMed Web of Science ®Google Scholar
• Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002;20..500–5.
   PubMed Web of Science ®Google Scholar
• Lee MT, Coburn GA, McClure MO, Cullen BR. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 2003;77:11964–72.
   PubMed Web of Science ®Google Scholar
• Park WS, Miyano-Kurosaki N, Hayafune M, Nakajima E, Matsuzaki T, Shimada F, et al. Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference. Nucleic Acids Res 2002;30:4830–5.
   PubMed Web of Science ®Google Scholar
• Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002;418: 435–8.
   Google Scholar
• Martinez MA, Gutierrez A, Armand-Ugon M, Blanco J, Parera M, Gomez J, et al. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 2002;16: 2385–90.
   Google Scholar
• Qin XF, An DS, Chen IS, Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2003;100:183–8.
   PubMed Web of Science ®Google Scholar
• Anderson J, Banerjea A, Planelles V, Akkina R. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA. AIDS Res Hum Retroviruses 2003;19:699–706.
   PubMed Web of Science ®Google Scholar
• Butticaz C, Ciuffi A, Munoz M, Thomas J, Bridge A, Pebernard S, et al. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antivir Ther 2003; 8: 373–7.
   PubMed Web of Science ®Google Scholar
• Adelman ZN, Blair CD, Carlson JO, Beaty BJ, Olson KR. Sindbis virus-induced silencing of dengue viruses in mosqui-toes. Insect Mol Biol 2001;10:265–73.
   Google Scholar
• Adelman ZN, Sanchez-Vargas I, Travanty EA, Carlson JO, Beaty BJ, Blair CD, et al. RNA silencing of dengue virus type 2 replication in transformed C6/36 mosquito cells transcrib-ing an inverted-repeat RNA derived from the virus genome. J Virol 2002;76:12925–33.
   PubMed Web of Science ®Google Scholar
• Caplen NJ, Zheng Z, Falgout B, Morgan RA. Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interference. Mol Ther 2002;6:243–251.
   PubMed Web of Science ®Google Scholar
• Kapadia SB, Brideau-Andersen A, Chisari FV. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA 2003;100:2014–8.
   PubMed Web of Science ®Google Scholar
• Seo MY, Abrignani S, Houghton M, Han JH. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J Virol 2003. 77:810–812.
   PubMed Web of Science ®Google Scholar
• Wilson JA, Jayasena S, Khvorova A, Sabatinos S, Rodrigue-Gervais IG, Arya S, et al. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci USA 2003;100:2783–8.
   Google Scholar
• Yokota T, Sakamoto N, Enomoto N, Tanabe Y, Miyagishi M, Maekawa S, et al. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep 2003;4:1–7.
   Web of Science ®Google Scholar
• Sen A, Steele R, Ghosh AK, Basu A, Ray R, Ray RB. Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res 2003;96:27–35.
   PubMed Web of Science ®Google Scholar
• Chang J, Taylor JM. Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action. J Virol 2003;77: 9728–31.
   PubMed Web of Science ®Google Scholar
• Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, Eisen HN, et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 2003;100:2718–23.
   PubMed Web of Science ®Google Scholar
• McCown M, Diamond MS, Pekosz A. The utility of siRNA transcripts produced by RNA polymerase I in down regulating viral gene expression and replication of negative-and positive-strand RNA viruses. Virology 2003;313:514–24.
   Google Scholar
• Ge Q, Filip L, Bai A, Nguyen T, Eisen HN, Chen J. Inhi-bition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci USA 2004;101:8676–81.
   PubMed Web of Science ®Google Scholar
• Tompkins SM, Lo CY, Tumpey TM, Epstein SL. Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci USA 2004;101:8682–6.
   PubMed Web of Science ®Google Scholar
• Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002;418:430–434.
   Google Scholar
• Phipps KM, Martinez A, Lu J, Heinz BA, Zhao G. Small interfering RNA molecules as potential anti-human rhino-virus agents: in vitro potency, specificity, and mechanism. Antiviral Res 2004;61:49–55.
   Google Scholar
• Dector MA, Romero P, Lopez S, Arias CF. Rotavirus gene silencing by small interfering RNAs. EMBO Rep 2002; 3: 1175–80.
   PubMed Web of Science ®Google Scholar
• Bitko V, Oldenburg A, Garmon NE, Bank S. Profilin is required for viral morphogenesis, syncytium formation, and cell-specific stress fiber induction by respiratory syncytial virus. BMC Microbiol 2003;3:9.
   PubMed Web of Science ®Google Scholar
• Bank S. Control of nonsegmented negative-strand RNA virus replication by siRNA. Virus Res 2004;102:27–35.
   PubMed Web of Science ®Google Scholar
• Hu WY, Myers CP, Kilzer JM, Pfaff SL, Bushman FD. Inhibition of retroviral pathogenesis by RNA interference. Curr Biol 2002;12:1301–11.
   Google Scholar
• Maggon K, Bank S. New drugs and treatment for respiratory syncytial virus. Rev Med Virol 2004;14:1–20.
   PubMed Web of Science ®Google Scholar
• Re MC, Bon I, Monari P, Borden i M, Gibellini D, Schiavone P, et al. Mutation patterns of the reverse transcriptase genes in HIV-1 infected patients receiving combinations of nucleo-side and non-nucleoside inhibitors. Int J Antimicrob Agents 2003;22: 388–94.
   Google Scholar
• Lin OS, Keeffe RB. Current treatment strategies for chronic hepatitis B and C. Annu Rev Med 2001;52:29–49.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Cullen BR. RNA interference in human cells is restricted to the cytoplasm. RNA 2002;8:855–60.
   PubMed Web of Science ®Google Scholar
• Zender L, Kubicka S. SiRNA based strategies for inhibition of apoptotic pathways in vivo analytical and therapeutic implications. Apoptosis 2004;9:51–4.
   PubMed Web of Science ®Google Scholar
• Song E, Lee SK, Wang J, Ince N, Ouyang N, MM J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003;9:347–51.
   PubMed Web of Science ®Google Scholar
• Zender L, Hutker S, Liedtke C, Tillmann HL, Zender S, Mundt B, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 2003;100: 7797–802.
   PubMed Web of Science ®Google Scholar
• McRobert L, McConkey GA. RNA interference (RNAi) inhibits growth of Plasmodium falciparum. Mol Biochem Parasitol 2002;119:273–8.
   PubMed Web of Science ®Google Scholar
• Malhotra P, Dasaradhi PV, Kumar A, Mohmmed A, Agrawal N, Bhatnagar RK, et al. Double-stranded RNA-mediated gene silencing of cysteine proteases (falcipain-1 and -2) of Plasmodium falciparum. Mol Microbiol 2002;45: 1245–54.
   PubMed Web of Science ®Google Scholar
• Kumar R, Adams B, Oldenburg A, Musiyenko A, Bank S. Characterisation and expression of a PP1 serine/threonine protein phosphatase (PEPP1) from the malaria parasite, Plasmodium falciparum: demonstration of its essential role using RNA interference. Malar J 2002;1: 5.
   Google Scholar
• Mohmmed A, Dasaradhi PV, Bhatnagar RK, Chauhan VS, Malhotra P. In vivo gene silencing in Plasmodium berghei-a mouse malaria model. Biochem Biophys Res Commun 2003; 309:506–11.
   Google Scholar
• Al-Anouti F, Ananvoranich S. Comparative analysis of anti-sense RNA, double-stranded RNA, and delta ribozyme-mediated gene regulation in Toxoplasma gondii. Antisense Nucleic Acid Drug Dev 2002;12:275–81.
   Google Scholar
• LaCount DJ, Bruse S, Hill KL, Donelson JR. Double-stranded RNA interference in Trypanosoma brucei using head-to-head promoters. Mol Biochem Parasitol 2000; 111: 67–76.
   PubMed Web of Science ®Google Scholar
• LaCount DJ, Barrett B, Donelson JR. Trypanosoma brucei FLA1 is required for flagellum attachment and cytokinesis. J Biol Chem 2002;277: 17580–8.
   Google Scholar
• Ullu E, Djikeng A, Shi H, Tschudi C. RNA interference: advances and questions. Philos Trans R Soc Lond B Biol Sci 2002;357:65–70.
   PubMed Web of Science ®Google Scholar
• Zoraghi R, Seebeck T. The cAMP-specific phosphodiesterase TbPDE2C is an essential enzyme in bloodstream form Trypanosoma brucei. Proc Natl Acad Sci USA 2002; 99: 4343–8.
   PubMed Web of Science ®Google Scholar
• Huynh TT, Huynh VT, Harmon MA, Phillips MA. Gene knockdown of gamma-glutamylcysteine synthetase by RNAi in the parasitic protozoa Trypanosoma brucei demonstrates that it is an essential enzyme. J Biol Chem 2003;278: 39794––800.
   Google Scholar
• Boyle JP, Wu XJ, Shoemaker CB, Yoshino TP. Using RNA interference to manipulate endogenous gene expression in Schistosoma mansoni sporocysts. Mol Biochem Parasitol 2003;128:205–15.
   PubMed Web of Science ®Google Scholar
• Skelly PJ, Da'dara A, Ham DA. Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference. Int J Parasitol 2003;33:363–9.
   Google Scholar
• Robinson KA, Beverley SM. Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania. Mol Biochem Para-sitol 2003;128:217–28.
   PubMed Web of Science ®Google Scholar
• DaRocha WD, Otsu K, Teixeira SM, Donelson JR. Tests of cytoplasmic RNA interference (RNAi) and construction of a tetracycline-inducible T7 promoter system in Trypanosoma cruzi. Mol Biochem Parasitol 2004;133:175–86.
   PubMed Web of Science ®Google Scholar
• Bertrand JR, Pottier M, Vekris A, Opolon P, Maksimenko A, Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 2002;296:1000–4.
   PubMed Web of Science ®Google Scholar
• Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 2003;9:210–6.
   PubMed Web of Science ®Google Scholar
• Lu M, Adamis AP. Vascular endothelial growth factor gene regulation and action in diabetic retinopathy. Ophthalmol Clin North Am 2002;15:69–79.
   PubMedGoogle Scholar
• Lage A, Crombet T, Gonzalez G. Targeting epidermal growth factor receptor signaling: early results and future trends in oncology. Ann Med 2003;35:327–36.
   Google Scholar
• Damm-Welk C, Fuchs U, Wossmann W, Borkhardt A. Targeting oncogenic fusion genes in leukemias and lympho-mas by RNA interference. Semin Cancer Biol 2003;13:283–92.
   Google Scholar
• Kovar H, Ban J, Pospisilova S. Potentials for RNAi in sarcoma research and therapy: Ewing's sarcoma as a model. Semin Cancer Biol 2003;13:275–81.
   Google Scholar
• Fluiter K, Housman D, Ten Asbroek AL, Baas F. Killing cancer by targeting genes that cancer cells have lost: allele-specific inhibition, a novel approach to the treatment of genetic disorders. Cell Mol Life Sci 2003;60:834–43.
   PubMed Web of Science ®Google Scholar
• Miller VM, Xia H, Marrs GL, Gouvion CM, Lee G, Davidson BL, et al. Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA 2003;100:7195–200.
   PubMed Web of Science ®Google Scholar
• Martinez LA, Naguibneva I, Lehrmann H, Vervisch A, Tchenio T, Lozano G, et al. Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc Natl Acad Sci USA 2002; 99: 14849–54.
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami R. Stable suppres-sion of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002;2:243–7.
   Google Scholar
• Ding H, Schwarz DS, Keene A, Affar el B, Fenton L, Xia X, et al. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2003;2:209–17.
   Google Scholar
• Li MJ, McMahon R, Snyder DS, Yee JK, Rossi JJ. Specific killing of Ph+ chronic myeloid leukemia cells by a lentiviral vector-delivered anti-bcr/abl small hairpin RNA. Oligonu-cleotides 2003;13:401–9.
   Google Scholar
• Ritter U, Damm-Welk C, Fuchs U, Bohle RM, Borkhardt A, Woessmann W. Design and evaluation of chemically synthesized siRNA targeting the NPM-ALK fusion site in anaplastic large cell lymphoma (ALCL). Oligonucleotides 2003;13:365–73.
   PubMed Web of Science ®Google Scholar
• Dohjima T, Lee NS, Li H, Ohno T, Rossi JJ. Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line. Mol Ther 2003;7: 811–6.
   Google Scholar
• Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone R J. Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 2003;9:153914.
   Google Scholar
• Xia XG, Zhou H, Ding H, AFFar el B, Shi Y, Xu Z. An enhanced U6 promoter for synthesis of short hairpin RNA. Nucleic Acids Res 2003;31:e100.
   Google Scholar
• Czauderna F, Santel A, Hinz M, Fechtner M, Durieux B, Fisch G, et al. Inducible shRNA expression for application in a prostate cancer mouse model. Nucleic Acids Res 2003;31: e127.
   PubMed Web of Science ®Google Scholar
• Arts GJ, Langemeijer E, Tissingh R, Ma L, Pavliska H, Dokic K, Dooijes R, et al. Adenoviral vectors expressing siRNAs for discovery and validation of gene function. Genome Res 2003;13:2325–32.
   PubMed Web of Science ®Google Scholar
• Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003;77:8957–61.
   PubMed Web of Science ®Google Scholar
• Matsukura S, Jones PA, Takai D. Establishment of condi-tional vectors for hairpin siRNA knockdowns. Nucleic Acids Res 2003;31:e77.
   PubMed Web of Science ®Google Scholar
• Somia N, Verma IM. Gene therapy: trials and tribulations. Nat Rev Genet 2000;1:91–9.
   PubMed Web of Science ®Google Scholar
• Amarzguioui M, Holen T, Babaie E, Prydz H. Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res 2003;31:589–95.
   PubMed Web of Science ®Google Scholar
• Hamada M, Ohtsuka T, Kawaida R, Koizumi M, Morita K, Furukawa H, et al. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mis-matches and the introduction of chemical modifications at the 3'-ends of siRNAs. Antisense Nucleic Acid Drug Dev 2002;12:301–9.
   PubMedGoogle Scholar
• Scherer LJ, Rossi JJ. Approaches for the sequence-specific knockdown of mRNA. Nat Biotechnol 2003;21:1457–65.
   PubMed Web of Science ®Google Scholar
• Becker J. Signal transduction inhibitors — a work in progress. Nat Biotechnol 2004;22:15–8.
   PubMed Web of Science ®Google Scholar
• Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, Bernards R, et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004;78:2601–5.
   PubMed Web of Science ®Google Scholar
• Schmitz JC, Chen TM, Chu E. Small interfering double-stranded RNAs as therapeutic molecules to restore chemo-sensitivity to thymidylate synthase inhibitor compounds. Cancer Res 2004;64:1431–5.
   Google Scholar
• Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 2004;22:326–30.
   PubMed Web of Science ®Google Scholar
• Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 2003;21:635–7.
   PubMed Web of Science ®Google Scholar
• Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res 2002;30:1757–66.
   Google Scholar
• Vickers TA, Koo S, Bennett CF, Crooke ST, Dean NM, Baker BF. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J Biol Chem 2003. 278:7108–18.
   PubMed Web of Science ®Google Scholar
• Howard K. Unlocking the money-making potential of RNAi. Nat Biotechnol 2003;21:1441–6.
   PubMed Web of Science ®Google Scholar